Back to Cardiology
Cardiologyv2023Evidence-Based

Systematic Coronary Risk Evaluation 2-Diabetes (SCORE2-Diabetes)

Predicts 10-year cardiovascular disease (fatal and non-fatal myocardial infarction and stroke) risk in patients with type 2 diabetes aged under 70 years without prior cardiovascular disease.

Clinical Input Parameters

years
Range: 40 — 69 years
mmHg
Range: 80 — 250 mmHg
mmol/L
Range: 2 — 12 mmol/L
mmol/L
Range: 0.5 — 3.5 mmol/L
years
Range: 18 — 69 years
mmol/mol
Range: 20 — 130 mmol/mol
mL/min/1.73m²
Range: 15 — 150 mL/min/1.73m²
Clinical Assessment
Awaiting Parameters
cvd risk
—%
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Systematic Coronary Risk Evaluation 2-Diabetes (SCORE2-Diabetes) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within cardiology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Uses Fine and Gray competing risk models with diabetes-specific variables (HbA1c, age at diagnosis, eGFR) added to conventional SCORE2 risk factors, calibrated to four European risk regions

Clinical Pearls & Practice Notes

  • For patients with type 2 diabetes aged 40-69 years without previous cardiovascular disease
  • Risk thresholds are age-specific: <50 years vs 50-69 years
  • Countries are grouped into four risk regions based on WHO CVD mortality rates
  • Consider diabetes-specific interventions (SGLT2i, GLP-1 RA) in addition to standard cardiovascular risk reduction
  • For patients ≥70 years, consider using SCORE2-OP

Evidence & Literature Citations

  1. SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur Heart J. 2023 Jul 21;44(28):2544-2556. doi: 10.1093/eurheartj/ehad260.
  2. Pennells L, Kaptoge S, Østergaard HB, Read SH, Carinci F, Franch-Nadal J, et al. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur Heart J. 2023 Jul 21;44(28):2544-2556.
  3. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.

Score Interpretation Ranges

Low to Moderate Risk0 – 2.5 pts

Low to moderate risk (<2.5% for age <50 years)

Moderate Risk2.5 – 5 pts

Moderate risk (2.5-5% for age <50 years or <5% for age 50-69 years)

High Risk5 – 7.5 pts

High risk (5-7.5% for age <50 years or 5-10% for age 50-69 years)

High Risk7.5 – 10 pts

High risk (7.5-10% for age 50-69 years)

Very High Risk10 – 100 pts

Very high risk (≥7.5% for age <50 years or ≥10% for age 50-69 years)

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.